✦ LIBER ✦

Refractory anemia with ringed sideroblasts associated with thrombocytosis: comparative analysis of marked with non-marked thrombocytosis, and relationship with JAK2 V617F mutational status

✍ Scribed by J. M. Raya; L. Arenillas; A. Domingo; B. Bellosillo; G. Gutiérrez; E. Luño; M. A. Piñán; M. Barbón; M. L. Pérez-Sirvent; M. J. Muruzábal; L. Yánez; L. García; A. Lemes; J. T. Navarro; A. Elosegi; M. A. Cortés; A. Villegas; M. A. Durán; M. Ardanaz; L. Florensa; On behalf of the Grupo Español de Citología Hematológica (GECH), Working Group into the Asociación Española de Hematología y Hemoterapia (AEHH)

Book ID: 107618620
Publisher: Carden Jennings Publishing
Year: 2008
Tongue: English
Weight: 316 KB
Volume: 88
Category: Article
ISSN: 0925-5710
DOI: 10.1007/s12185-008-0169-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High occurrence of JAK2 V617 mutation in

High occurrence of JAK2 V617 mutation in refractory anemia with ringed sideroblasts associated with marked thrombocytosis

✍ Renneville, A; Quesnel, B; Charpentier, A; Terriou, L; Crinquette, A; Laï, J-L; 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 104 KB

Refractory anemia with ringed sideroblas

Refractory anemia with ringed sideroblasts associated with marked thrombocytosis harbors JAK2 mutation and shows overlapping myeloproliferative and myelodysplastic features

✍ Wang, S A; Hasserjian, R P; Loew, J M; Sechman, E V; Jones, D; Hao, S; Liu, Q; Z 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 102 KB

Prognostic interaction between thrombocy

Prognostic interaction between thrombocytosis and JAK2 V617F mutation in the WHO subcategories of myelodysplastic/myeloproliferative disease-unclassifiable and refractory anemia with ringed sideroblasts and marked thrombocytosis

✍ Atallah, E; Nussenzveig, R; Yin, C C; Bueso-Ramos, C; Tam, C; Manshouri, T; Pier 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 111 KB